logo

For the Inventor, By the Inventor

San Francisco, CA, United States of America

Napo Pharmaceuticals, Inc.


USPTO Granted Patents = 15



Trademarks = 2

Forward Citations = 87

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Barry D Quart (6 out of 19 patents)

silverMedal Pravin R Chaturvedi (6 out of 12 patents)

bronzeMedal David P Rosenbaum (4 out of 5 patents)

4.  Lisa A Conte (3 out of 3 patents)

5.  William Forbes (2 out of 27 patents)

6.  Enoch Bortey (2 out of 19 patents)

7.  Robert C Blanks (2 out of 13 patents)

8.  Thomas Neenan (2 out of 2 patents)

9.  Edward James Rozhon (2 out of 3 patents)

10.  Atul S Khandwala (2 out of 4 patents)

11.  Akram Sabouni (2 out of 3 patents)

12.  Gul P Balwani (2 out of 4 patents)

13.  Jody Wai-Han Chan (2 out of 3 patents)

14.  David F Sesin (2 out of 3 patents)

15.  Steven Row King (2 out of 5 patents)


15 patents:

1. 11857510 - Methods and compositions for treating congenital diarrhea disorder (2024-01-02),
2. 11779564 - Methods and compositions for treating bile acid diarrhea, diarrhea associated with small intestine resection or gallbladder removal, and short bowel syndrome (2023-10-10),
3. 11389424 - Methods and compositions for treating chemotherapy-induced diarrhea (2022-07-19),
4. 9987250 - Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer (2018-06-05),
5. 9980938 - Method for treatment of diarrhea-predominant irritable bowel syndrome (2018-05-29),
6. 9585868 - Methods and compositions for treating HIV-associated diarrhea (2017-03-07),
7. 9314437 - Pharmacologically optimized multimodal drug delivery system for nordihydroguiaretic acid (NDGA) (2016-04-19),
8. 9198879 - Pharmacologically optimized multimodal drug delivery system for nordihydroguiaretic acid (NDGA) (2015-12-01),
9. 9138450 - Method for treatment of constipation-predominant irritable bowel syndrome (2015-09-22),
10. 8962680 - Methods and compositions for treating HIV-associated diarrhea (2015-02-24),
11. 8852649 - Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer (2014-10-07),
12. 8846113 - Method for treatment of diarrhea-predominant irritable bowel syndrome (2014-09-30),
13. 7556831 - Method for treatment of constipation-predominant irritable bowel syndrome (2009-07-07),
14. 7341744 - Method of treating secretory diarrhea with enteric formulations of proanthocyanidin polymer (2008-03-11),
15. 7323195 - Enteric formulations of proanthocyanidin polymer antidiarrheal compositions (2008-01-29),
NAPO Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing novel therapies for various diseases. With a strong commitment to innovation and scientific research, NAPO aims to improve patient outcomes and quality of life. Visit their website to learn more about their groundbreaking drug development programs and contributions to the healthcare industry.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
15 Patents

#307 in San Francisco, CA

#4,873 in California

#20,436 in US

#38,730 in the World

...
San Francisco, CA, United States of America

Napo Pharmaceuticals, Inc.

Forward Citations = 87

16 inventors:

goldMedal Barry D Quart (6 out of 19 patents)

silverMedal Pravin R Chaturvedi (6 out of 12 patents)

bronzeMedal David P Rosenbaum (4 out of 5 patents)

4.  Lisa A Conte (3 out of 3 patents)

5.  William Forbes (2 out of 27 patents)

Please report any incorrect information to support@idiyas.com
Loading…